カテゴリー： QYResearch, 世界, 医療/バイオ

世界のメロペネム粉末市場インサイト及び予測（純度98％以上、純度99％以上）

◆英語タイトル：Global Meropenem Powder Market Insights, Forecast to 2028
	◆商品コード：QY22JLX10410 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：116 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、メロペネム粉末のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にメロペネム粉末の世界市場のxxx％を占める「純度98％以上」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「皮膚感染症」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
メロペネム粉末の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのメロペネム粉末市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

メロペネム粉末のグローバル主要企業には、Pfizer、AuroMedics、Sandoz、Amneal Pharmaceuticals、Sumitomo Dainippon Pharma、Ranbaxy Laboratories、Mylan、Sagent Pharmaceuticals、Macleods Pharmaceuticals、Shenzhen Haibin Pharmaceutical、Chongqing Tiandi Pharmaceutical、PKU HealthCare、United Laboratories、CSPC Group、Zhejiang Hisun Pharmaceutical、Luoxin Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

メロペネム粉末市場は、種類と用途によって区分されます。世界のメロペネム粉末市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
純度98％以上、純度99％以上

【用途別セグメント】
皮膚感染症、細菌性髄膜炎、肺炎、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- メロペネム粉末製品概要
- 種類別市場（純度98％以上、純度99％以上）
- 用途別市場（皮膚感染症、細菌性髄膜炎、肺炎、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のメロペネム粉末販売量予測2017-2028
- 世界のメロペネム粉末売上予測2017-2028
- メロペネム粉末の地域別販売量
- メロペネム粉末の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別メロペネム粉末販売量
- 主要メーカー別メロペネム粉末売上
- 主要メーカー別メロペネム粉末価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（純度98％以上、純度99％以上）
- メロペネム粉末の種類別販売量
- メロペネム粉末の種類別売上
- メロペネム粉末の種類別価格
・用途別市場規模（皮膚感染症、細菌性髄膜炎、肺炎、その他）
- メロペネム粉末の用途別販売量
- メロペネム粉末の用途別売上
- メロペネム粉末の用途別価格
・北米市場
- 北米のメロペネム粉末市場規模（種類別、用途別）
- 主要国別のメロペネム粉末市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのメロペネム粉末市場規模（種類別、用途別）
- 主要国別のメロペネム粉末市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のメロペネム粉末市場規模（種類別、用途別）
- 主要国別のメロペネム粉末市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のメロペネム粉末市場規模（種類別、用途別）
- 主要国別のメロペネム粉末市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのメロペネム粉末市場規模（種類別、用途別）
- 主要国別のメロペネム粉末市場規模（トルコ、サウジアラビア）
・企業情報
Pfizer、AuroMedics、Sandoz、Amneal Pharmaceuticals、Sumitomo Dainippon Pharma、Ranbaxy Laboratories、Mylan、Sagent Pharmaceuticals、Macleods Pharmaceuticals、Shenzhen Haibin Pharmaceutical、Chongqing Tiandi Pharmaceutical、PKU HealthCare、United Laboratories、CSPC Group、Zhejiang Hisun Pharmaceutical、Luoxin Pharmaceutical
・産業チェーン及び販売チャネル分析
- メロペネム粉末の産業チェーン分析
- メロペネム粉末の原材料
- メロペネム粉末の生産プロセス
- メロペネム粉末の販売及びマーケティング
- メロペネム粉末の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- メロペネム粉末の産業動向
- メロペネム粉末のマーケットドライバー
- メロペネム粉末の課題
- メロペネム粉末の阻害要因
・主な調査結果

Market Analysis and Insights: Global Meropenem Powder Market
Due to the COVID-19 pandemic, the global Meropenem Powder market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity Greater than or Equal to 98% accounting for % of the Meropenem Powder global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Skin Infection segment is altered to an % CAGR throughout this forecast period.
China Meropenem Powder market size is valued at US$ million in 2021, while the US and Europe Meropenem Powder are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Meropenem Powder landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Meropenem Powder include Pfizer, AuroMedics, Sandoz, Amneal Pharmaceuticals, Sumitomo Dainippon Pharma, Ranbaxy Laboratories, Mylan, Sagent Pharmaceuticals and Macleods Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Meropenem Powder Scope and Segment
Meropenem Powder market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Meropenem Powder market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity Greater than or Equal to 98%
Purity Greater than or Equal to 99%
Segment by Application
Skin Infection
Bacterial Meningitis
Pneumonia
Others
By Company
Pfizer
AuroMedics
Sandoz
Amneal Pharmaceuticals
Sumitomo Dainippon Pharma
Ranbaxy Laboratories
Mylan
Sagent Pharmaceuticals
Macleods Pharmaceuticals
Shenzhen Haibin Pharmaceutical
Chongqing Tiandi Pharmaceutical
PKU HealthCare
United Laboratories
CSPC Group
Zhejiang Hisun Pharmaceutical
Luoxin Pharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Meropenem Powder Product Introduction
1.2 Market by Type
1.2.1 Global Meropenem Powder Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Purity Greater than or Equal to 98%
1.2.3 Purity Greater than or Equal to 99%
1.3 Market by Application
1.3.1 Global Meropenem Powder Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Skin Infection
1.3.3 Bacterial Meningitis
1.3.4 Pneumonia
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Meropenem Powder Sales Estimates and Forecasts 2017-2028
2.2 Global Meropenem Powder Revenue Estimates and Forecasts 2017-2028
2.3 Global Meropenem Powder Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Meropenem Powder Sales by Region
2.4.1 Global Meropenem Powder Sales by Region (2017-2022)
2.4.2 Global Sales Meropenem Powder by Region (2023-2028)
2.5 Global Meropenem Powder Revenue by Region
2.5.1 Global Meropenem Powder Revenue by Region (2017-2022)
2.5.2 Global Meropenem Powder Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Meropenem Powder Sales by Manufacturers
3.1.1 Global Top Meropenem Powder Manufacturers by Sales (2017-2022)
3.1.2 Global Meropenem Powder Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Meropenem Powder in 2021
3.2 Global Meropenem Powder Revenue by Manufacturers
3.2.1 Global Meropenem Powder Revenue by Manufacturers (2017-2022)
3.2.2 Global Meropenem Powder Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Meropenem Powder Revenue in 2021
3.3 Global Meropenem Powder Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Meropenem Powder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Meropenem Powder Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Meropenem Powder Sales by Type
4.1.1 Global Meropenem Powder Historical Sales by Type (2017-2022)
4.1.2 Global Meropenem Powder Forecasted Sales by Type (2023-2028)
4.1.3 Global Meropenem Powder Sales Market Share by Type (2017-2028)
4.2 Global Meropenem Powder Revenue by Type
4.2.1 Global Meropenem Powder Historical Revenue by Type (2017-2022)
4.2.2 Global Meropenem Powder Forecasted Revenue by Type (2023-2028)
4.2.3 Global Meropenem Powder Revenue Market Share by Type (2017-2028)
4.3 Global Meropenem Powder Price by Type
4.3.1 Global Meropenem Powder Price by Type (2017-2022)
4.3.2 Global Meropenem Powder Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Meropenem Powder Sales by Application
5.1.1 Global Meropenem Powder Historical Sales by Application (2017-2022)
5.1.2 Global Meropenem Powder Forecasted Sales by Application (2023-2028)
5.1.3 Global Meropenem Powder Sales Market Share by Application (2017-2028)
5.2 Global Meropenem Powder Revenue by Application
5.2.1 Global Meropenem Powder Historical Revenue by Application (2017-2022)
5.2.2 Global Meropenem Powder Forecasted Revenue by Application (2023-2028)
5.2.3 Global Meropenem Powder Revenue Market Share by Application (2017-2028)
5.3 Global Meropenem Powder Price by Application
5.3.1 Global Meropenem Powder Price by Application (2017-2022)
5.3.2 Global Meropenem Powder Price Forecast by Application (2023-2028)
6 North America
6.1 North America Meropenem Powder Market Size by Type
6.1.1 North America Meropenem Powder Sales by Type (2017-2028)
6.1.2 North America Meropenem Powder Revenue by Type (2017-2028)
6.2 North America Meropenem Powder Market Size by Application
6.2.1 North America Meropenem Powder Sales by Application (2017-2028)
6.2.2 North America Meropenem Powder Revenue by Application (2017-2028)
6.3 North America Meropenem Powder Market Size by Country
6.3.1 North America Meropenem Powder Sales by Country (2017-2028)
6.3.2 North America Meropenem Powder Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Meropenem Powder Market Size by Type
7.1.1 Europe Meropenem Powder Sales by Type (2017-2028)
7.1.2 Europe Meropenem Powder Revenue by Type (2017-2028)
7.2 Europe Meropenem Powder Market Size by Application
7.2.1 Europe Meropenem Powder Sales by Application (2017-2028)
7.2.2 Europe Meropenem Powder Revenue by Application (2017-2028)
7.3 Europe Meropenem Powder Market Size by Country
7.3.1 Europe Meropenem Powder Sales by Country (2017-2028)
7.3.2 Europe Meropenem Powder Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Meropenem Powder Market Size by Type
8.1.1 Asia Pacific Meropenem Powder Sales by Type (2017-2028)
8.1.2 Asia Pacific Meropenem Powder Revenue by Type (2017-2028)
8.2 Asia Pacific Meropenem Powder Market Size by Application
8.2.1 Asia Pacific Meropenem Powder Sales by Application (2017-2028)
8.2.2 Asia Pacific Meropenem Powder Revenue by Application (2017-2028)
8.3 Asia Pacific Meropenem Powder Market Size by Region
8.3.1 Asia Pacific Meropenem Powder Sales by Region (2017-2028)
8.3.2 Asia Pacific Meropenem Powder Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Meropenem Powder Market Size by Type
9.1.1 Latin America Meropenem Powder Sales by Type (2017-2028)
9.1.2 Latin America Meropenem Powder Revenue by Type (2017-2028)
9.2 Latin America Meropenem Powder Market Size by Application
9.2.1 Latin America Meropenem Powder Sales by Application (2017-2028)
9.2.2 Latin America Meropenem Powder Revenue by Application (2017-2028)
9.3 Latin America Meropenem Powder Market Size by Country
9.3.1 Latin America Meropenem Powder Sales by Country (2017-2028)
9.3.2 Latin America Meropenem Powder Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Meropenem Powder Market Size by Type
10.1.1 Middle East and Africa Meropenem Powder Sales by Type (2017-2028)
10.1.2 Middle East and Africa Meropenem Powder Revenue by Type (2017-2028)
10.2 Middle East and Africa Meropenem Powder Market Size by Application
10.2.1 Middle East and Africa Meropenem Powder Sales by Application (2017-2028)
10.2.2 Middle East and Africa Meropenem Powder Revenue by Application (2017-2028)
10.3 Middle East and Africa Meropenem Powder Market Size by Country
10.3.1 Middle East and Africa Meropenem Powder Sales by Country (2017-2028)
10.3.2 Middle East and Africa Meropenem Powder Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Meropenem Powder Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Meropenem Powder Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 AuroMedics
11.2.1 AuroMedics Corporation Information
11.2.2 AuroMedics Overview
11.2.3 AuroMedics Meropenem Powder Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AuroMedics Meropenem Powder Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AuroMedics Recent Developments
11.3 Sandoz
11.3.1 Sandoz Corporation Information
11.3.2 Sandoz Overview
11.3.3 Sandoz Meropenem Powder Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sandoz Meropenem Powder Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sandoz Recent Developments
11.4 Amneal Pharmaceuticals
11.4.1 Amneal Pharmaceuticals Corporation Information
11.4.2 Amneal Pharmaceuticals Overview
11.4.3 Amneal Pharmaceuticals Meropenem Powder Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Amneal Pharmaceuticals Meropenem Powder Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Amneal Pharmaceuticals Recent Developments
11.5 Sumitomo Dainippon Pharma
11.5.1 Sumitomo Dainippon Pharma Corporation Information
11.5.2 Sumitomo Dainippon Pharma Overview
11.5.3 Sumitomo Dainippon Pharma Meropenem Powder Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sumitomo Dainippon Pharma Meropenem Powder Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sumitomo Dainippon Pharma Recent Developments
11.6 Ranbaxy Laboratories
11.6.1 Ranbaxy Laboratories Corporation Information
11.6.2 Ranbaxy Laboratories Overview
11.6.3 Ranbaxy Laboratories Meropenem Powder Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Ranbaxy Laboratories Meropenem Powder Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ranbaxy Laboratories Recent Developments
11.7 Mylan
11.7.1 Mylan Corporation Information
11.7.2 Mylan Overview
11.7.3 Mylan Meropenem Powder Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Mylan Meropenem Powder Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Mylan Recent Developments
11.8 Sagent Pharmaceuticals
11.8.1 Sagent Pharmaceuticals Corporation Information
11.8.2 Sagent Pharmaceuticals Overview
11.8.3 Sagent Pharmaceuticals Meropenem Powder Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sagent Pharmaceuticals Meropenem Powder Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sagent Pharmaceuticals Recent Developments
11.9 Macleods Pharmaceuticals
11.9.1 Macleods Pharmaceuticals Corporation Information
11.9.2 Macleods Pharmaceuticals Overview
11.9.3 Macleods Pharmaceuticals Meropenem Powder Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Macleods Pharmaceuticals Meropenem Powder Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Macleods Pharmaceuticals Recent Developments
11.10 Shenzhen Haibin Pharmaceutical
11.10.1 Shenzhen Haibin Pharmaceutical Corporation Information
11.10.2 Shenzhen Haibin Pharmaceutical Overview
11.10.3 Shenzhen Haibin Pharmaceutical Meropenem Powder Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Shenzhen Haibin Pharmaceutical Meropenem Powder Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Shenzhen Haibin Pharmaceutical Recent Developments
11.11 Chongqing Tiandi Pharmaceutical
11.11.1 Chongqing Tiandi Pharmaceutical Corporation Information
11.11.2 Chongqing Tiandi Pharmaceutical Overview
11.11.3 Chongqing Tiandi Pharmaceutical Meropenem Powder Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Chongqing Tiandi Pharmaceutical Meropenem Powder Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Chongqing Tiandi Pharmaceutical Recent Developments
11.12 PKU HealthCare
11.12.1 PKU HealthCare Corporation Information
11.12.2 PKU HealthCare Overview
11.12.3 PKU HealthCare Meropenem Powder Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 PKU HealthCare Meropenem Powder Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 PKU HealthCare Recent Developments
11.13 United Laboratories
11.13.1 United Laboratories Corporation Information
11.13.2 United Laboratories Overview
11.13.3 United Laboratories Meropenem Powder Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 United Laboratories Meropenem Powder Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 United Laboratories Recent Developments
11.14 CSPC Group
11.14.1 CSPC Group Corporation Information
11.14.2 CSPC Group Overview
11.14.3 CSPC Group Meropenem Powder Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 CSPC Group Meropenem Powder Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 CSPC Group Recent Developments
11.15 Zhejiang Hisun Pharmaceutical
11.15.1 Zhejiang Hisun Pharmaceutical Corporation Information
11.15.2 Zhejiang Hisun Pharmaceutical Overview
11.15.3 Zhejiang Hisun Pharmaceutical Meropenem Powder Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Zhejiang Hisun Pharmaceutical Meropenem Powder Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Zhejiang Hisun Pharmaceutical Recent Developments
11.16 Luoxin Pharmaceutical
11.16.1 Luoxin Pharmaceutical Corporation Information
11.16.2 Luoxin Pharmaceutical Overview
11.16.3 Luoxin Pharmaceutical Meropenem Powder Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Luoxin Pharmaceutical Meropenem Powder Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Luoxin Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Meropenem Powder Industry Chain Analysis
12.2 Meropenem Powder Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Meropenem Powder Production Mode & Process
12.4 Meropenem Powder Sales and Marketing
12.4.1 Meropenem Powder Sales Channels
12.4.2 Meropenem Powder Distributors
12.5 Meropenem Powder Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Meropenem Powder Industry Trends
13.2 Meropenem Powder Market Drivers
13.3 Meropenem Powder Market Challenges
13.4 Meropenem Powder Market Restraints
14 Key Findings in The Global Meropenem Powder Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のメロペネム粉末市場インサイト及び予測（純度98％以上、純度99％以上）(Global Meropenem Powder Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のメロペネム粉末市場インサイト及び予測（純度98％以上、純度99％以上）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp